Aspira Women's Health Inc. (AWHL) stock
AWHLOTCIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$0.22−0.01 (-2.61%)
Close on Oct 19, 2026Market cap $9.91MP/E –Yield –
Aspira Women's Health operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Aspira Women's Health's operating income for the twelve months ending Jun 30, 2026 was -$6.90M. For fiscal 2025 it was -$7.91M. The highest annual figure on record is -$7.91M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$7.91M | – |
| FY2024 | Dec 31, 2024 | -$16.28M | – |
| FY2023 | Dec 31, 2023 | -$18.85M | – |
| FY2022 | Dec 31, 2022 | -$31.14M | – |
| FY2021 | Dec 31, 2021 | -$32.60M | – |
| FY2020 | Dec 31, 2020 | -$17.98M | – |
| FY2019 | Dec 31, 2019 | -$15.28M | – |
| FY2018 | Dec 31, 2018 | -$11.33M | – |
| FY2017 | Dec 31, 2017 | -$10.44M | – |
| FY2016 | Dec 31, 2016 | -$14.95M | – |
| FY2015 | Dec 31, 2015 | -$19.25M | – |
| FY2014 | Dec 31, 2014 | -$19.21M | – |
| FY2013 | Dec 31, 2013 | -$8.86M | – |
| FY2012 | Dec 31, 2012 | -$9.41M | – |
| FY2011 | Dec 31, 2011 | -$17.64M | – |
| FY2010 | Dec 31, 2010 | -$14.60M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.84M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.20M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.28M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.58M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.81M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.24M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.43M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.74M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.39M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.71M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.14M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.12M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.32M | – |
| Q1 FY2023 | Mar 31, 2023 | -$6.28M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.09M | – |
| Q3 FY2022 | Sep 30, 2022 | -$8.58M | – |
| Q2 FY2022 | Jun 30, 2022 | -$8.22M | – |
| Q1 FY2022 | Mar 31, 2022 | -$9.25M | – |
| Q4 FY2021 | Dec 31, 2021 | -$8.95M | – |
| Q3 FY2021 | Sep 30, 2021 | -$9.69M | – |
| Q2 FY2021 | Jun 30, 2021 | -$8.07M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.89M | – |
| Q4 FY2020 | Dec 31, 2020 | -$6.07M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.28M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.83M | – |
| Q1 FY2020 | Mar 31, 2020 | -$3.80M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.40M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.85M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.31M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.72M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.82M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.64M | – |
| Q2 FY2018 | Jun 30, 2018 | -$3.03M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.84M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.94M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.50M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.35M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.66M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.83M | – |
| Q3 FY2016 | Sep 30, 2016 | -$3.47M | – |
See a number that looks wrong?